Socioeconomic benefits from adequate correction of iron deficiency in pregnant women


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The analysis of the economic aspects of medical technologies used to resolve iron def iciency/anemia in pregnant/ parturient/puerperal women is aimed at identifying the most effective tactics to improve healthcare quality in obstetrics and to save health resources. Objective: To assess the potential country and applied health benefits in the transition from the established practice to the optimized practice in the correction of iron def iciency/iron def iciency anemia in pregnant women. Materials and methods: Socioeconomic damage and its monetary expression from the outcomes of pregnancies in the presence of iron def iciency/iron def iciency anemia were assessed, by estimating the years of life lost/saved (the Global Burden of Disease concept). Potentially preventable damage and applied health benefits were calculated within the framework of a simulation model that assumes timely and adequate therapeutic correction of prenatal iron deficiency/anemia as a component of a package of measures for patient blood management, by taking into account the likely outcomes when changing the treatment policy. The material to be analyzed was data from the medical records of 292 pregnant women diagnosed with iron deficiency anemia. Results: When patient blood management was comprehensively implemented in obstetrics, the socioeconomic damage could potentially decrease by 5.6 times due to a reduction in the monetary equivalent of specific losses during spontaneous labor (by 94.6%) and during cesarean section delivery (by 58.6%). The positive impact of timely and adequate correction of iron def iciency in pregnant women on the financial-and-economic component of healthcare was expressed in the annual savings of more than 2.5 billion rubles due to the reduction in the excess days of maternity hospital stay in the puerperal women and to the exclusion of transfusions of 72,473 liters of blood products. Conclusion: Timely diagnosis, individual selection, and an adequate procedure for administering iron-containing agents will provide for a decrease in social losses.

Full Text

Restricted Access

About the authors

Ekaterina O. Kurilovich

National Research University Higher School of Economics

Email: k-ekaterina-o@mail.ru
Expert, Institute of Health Economics 109074, Russia, Moscow, Slavyanskaya sqr., 4 build. 2

Olga I. Volkova

National Research University Higher School of Economics

Email: ovolkova08@mail.ru
Expert, Institute of Health Economics 109074, Russia, Moscow, Slavyanskaya sqr., 4 build. 2

Tatiana A. Fedorova

Academician V.I.Kulakov National Medical Research Center of Obstetrics, Gynecology and Perinatology Ministry of Health of the Russian Federation

Email: t_fyodorova@oparina4.ru
Dr. Med. Sci., Professor, Head of Transfusional Department 117997, Russia, Moscow , Ас. Oparm str., 4

Vladislav V. Golubtsov

Kuban State Medical University Ministry of Health of the Russian Federation

Email: golubtsovv@mailru
Dr. Med. Sci., Professor of the Department of Anesthesiology, Reanimatology and Transfusiology 350063, Russia, Krasnodar, Mitrofana Sedina str., 4

Larisa D. Popovich

National Research University Higher School of Economics

Email: ldpopovich@hse.ru
PhD (Bio), Director, Institute of Health Economics 109074, Russia, Moscow, Slavyanskaya sqr., 4 build. 2

Margarita D. Andreeva

Kuban State Medical University Ministry of Health of the Russian Federation

Email: andreeva_md@mail.ru
Dr. Med. Sci., Professor of the Department of Obstetrics, Gynecology and Perinatology of the FPK and the Teaching Staff 350063, Russia, Krasnodar, Mitrofana Sedina str., 4

Natalya A. Barkovskaya

Volga Research Medical University Ministry of Health of the Russian Federation

Email: bar-natalya@mail.ru
PhD, Head of Anaesthesiology and Reanimation Department, Dzerzhinsk Perinatal Center; Assistant, Department of Obstetrics and Gynaecology, Faculty of Additional Professional Education 603950, Russia, Nizhny Novgorod, Minin and Pozharsky Sqr., 10/1

Roman G. Shmakov

Academician V.I.Kulakov National Medical Research Center of Obstetrics, Gynecology and Perinatology Ministry of Health of the Russian Federation

Email: r_shmakov@oparina4.ru
Dr. Med. Sci., Professor, Director of the Institute of Obstetrics 117997, Russia, Moscow, Ас. Oparm str., 4

Asya N. Akhidzhak

Kuban State Medical University Ministry of Health of the Russian Federation

Email: ahidzhak.asya@mailru
Head of the Maternity Department of the Perinatal Center 350012, Russia, Krasnodar, Red Partizan str., 6/2

Ksenia G. Khamidulina

Academician V.I.Kulakov National Medical Research Center of Obstetrics, Gynecology and Perinatology Ministry of Health of the Russian Federation

Email: k_bykova@oparina4.ru
PhD, Researcher of the Department of Extracorporeal Methods of Treatment and Detoxification 117997, Russia, Moscow, Ac. Oparina str., 4

References

  1. Коноводова Е.Н., Якунина Н.А. Железодефицитные состояния и беременность. РМЖ. Мать и дитя. 2010; 18(19): 1174-8.
  2. Соловьева А.В., Оленев А.С., Гаче В., Хорольский В.А., Кузнецова О.А. Анемии у женщин репродуктивного возраста. Вопросы гинекологии. Акушерства и перинатологии. 2016; 15(4): 59-62.
  3. Основные показатели здоровья матери и ребенка, деятельность службы охраны детства и родовспоможения в Российской Федерации. МЗ РФ, ЦНИИОИЗ; 2020.
  4. Федеральные клинические рекомендации «Диагностика, профилактика и лечение железодефицитных состояний у беременных и родильниц». Российское общество акушеров-гинекологов, ФГБУ «Научный Центр акушерства, гинекологии и перинатологии им. В.И. Кулакова» МЗ России. Москва; 2013.
  5. Filippi V., Chou D., Ronsmans C., Graham W., Say L. Levels and Causes of Maternal Mortality and Morbidity. In: Reproductive, Maternal, Newborn, and Child Health: Disease Control Priorities, Third Edition (Volume 2). Washington (DC): The International Bank for Reconstruction and Development/The World Bank; 2016 Apr 5. Chapter 3. https://doi.org/10.1596/978-1-4648-0348-2_ch3
  6. Lumbiganon P., Laopaiboon M., Intarut N., Vogel J.P., Souza J.P., Gtilmezoglu A.M., Mori R.; WHO Multicountry Survey on Maternal and Newborn Health Research Network. Indirect causes of severe adverse maternal outcomes: a secondary analysis of the WHO Multicountry Survey on Maternal and Newborn Health. BJOG. 2014; 121 (Suppl 1): 32-9. https://doi.org/10.1111/1471-0528.12647.
  7. New S., Wirth M. Anaemia, pregnancy, and maternal mortality: the problem with globally standardised haemoglobin cutoffs. BJOG. 2015; 122(2): 166-9. https://doi.org/10.1111/1471-0528.13225.
  8. Reveiz L., Gyte G.M.L., Cuervo L.G., Casasbuenas A. Treatments for iron-deficiency anaemia in pregnancy. Cochrane Database Syst Rev. 2011; 10: CD003094. https://doi.org/10.1002/14651858.CD003094.pub3.
  9. Коноводова Е.Н., Бурлев В.А. Железодефицитные состояния у беременных и родильниц. Акушерство и гинекология. 2012; 1: 137-42.
  10. Hofmann A., Ozawa S., Farrugia A., Farmer S.L., Shander A. Economic considerations on transfusion medicine and patient blood management. Best Pract Res Clin Anaesthesiol. 2013; 27(1): 59-68. https://doi.org/10.1016/j.bpa.2013.02.001.
  11. Meybohm P., Straub N., Fullenbach C., Judd L., Kleineruschkamp A., Taeuber I., Zacharowski K., Choorapoikayil S. Health economics of Patient Blood Management: a cost-benefit analysis based on a meta-analysis. Vox Sang. 2020; 115(2): 182-8. https://doi.org/10.1111/vox.12873.
  12. Murray C.J.L., Lopez A.D. Measuring the Global Burden of Disease. N Engl J Med. 2013; 369(5): 448-57. https://doi.org/10.1056/NEJMra1201534.
  13. Голухова Е.З., Купряшов А.А., Хичева Г.А., Куксина Е.В, Волкова О.И., Курилович Е.О., Попович Л.Д. Оценка социально-экономических выгод от внедрения менеджмента крови пациентов в практику оперативных вмешательств по поводу ИБС (I20-I25). Кардиология. 2021; 61(3); 47-56. https://doi.org/10.18087/cardio.2021.3.n1557.
  14. Hofmann A., Farmer S., Towler S.C. Strategies to preempt and reduce the use of blood products: an Australian perspective. Curr Opin Anaesthesiol. 2012; 25(1): 66-73. https://doi.org/10.1097/ACO.0b013e32834eb726.
  15. Голубцов В.В. Менеджмент крови пациента. Опыт использования. План организации процесса по внедрению. Презентация на Международном совещании экспертов «Внедрение менеджмента крови пациента в клиническую практику в Российской Федерации», 11 декабря 2019 г. (показатель стоимости в 2016 г. с индексацией до уровня 2020 г.).
  16. Кровесберегающие технологии в акушерской практике. Клинические рекомендации (протокол). Письмо МЗ РФ от 27 мая 2014 г. N 15-4/10/2-3798.
  17. Munoz M., Pena-Rosas J. P., Robinson S., Milman N., Holzgreve W., Breymann C., Goffinet F., Nizard J., Christory F., Samama C.-M., Hardy J.-F Patient blood management in obstetrics: management of anaemia and haematinic deficiencies in pregnancy and in the post-partum period: NATA consensus statement. Transfus Med. 2018; 28(1): 22-39. https://doi.org/10.1111/tme.12443.
  18. Основные показатели здравоохранения в РФ. МЗ, ЦНИИОЗ. Часть VI. Москва; 2020.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies